Evidence map›Paper›PMID 35744976›Full record

ArticleMolecules (Basel, Switzerland)2022

Discovery of Quinazoline-2,4(1

Nader M Boshta, Farag A El-Essawy, Mohammed B Alshammari, Safaa G Noreldein, Osama M Darwesh

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Potential Antioxidant Compounds from the Spores ofAntioxidants (Basel, Switzerland) · 2024
    Article
  3. Synthesis of 3-(Pyridin-2-yl)quinazolin-2,4(1International journal of molecular sciences · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Nader M BoshtaChemistry Department, Faculty of Science, Menoufia University, Shebin El-Koam 32511, Egypt.ORCID 0000-0002-4874-651X
Farag A El-EssawyPreparatory Year Deanship, Basic Science Department, Prince Sattam Bin Abdulaziz University, P.O. Box 151, Alkharj 11942, Saudi Arabia.ORCID 0000-0003-0683-325X
Mohammed B AlshammariCollege of Sciences and Humanities, Prince Sattam Bin Abdulaziz University, P.O. Box 151, Alkharj 11942, Saudi Arabia.ORCID 0000-0001-9687-8747
Safaa G NoreldeinChemistry Department, Faculty of Science, Menoufia University, Shebin El-Koam 32511, Egypt.
Osama M DarweshEnvironmental Microbiology and Nanotechnology Group, Agricultural Microbiology Department, National Research Centre, Cairo 12622, Egypt.ORCID 0000-0002-7742-4982
Menoufia University · EGPrince Sattam Bin Abdulaziz University · SANational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we report on the design and synthesis of a novel series of quinazoline-2,4(1

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsGram-Negative BacteriaMicrobial Sensitivity TestsQuinazolinesStructure-Activity RelationshipAnti-Bacterial AgentsAnti-Infective AgentsQuinazolinesantimicrobialfluoroquinolonesquinazolinequinazoline-2,4(1H,3H)-dionesynthesis

Identifiers

PMID35744976
PMCPMC9228007
OpenAlexW4283031455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.